The results show that there is a significant difference in the expression of CTLA-4/LAG-3/TIGIT/VISTA between the two groups, suggesting that the mechanism of the effect of macropinocytosis on the progression of HCC may be related to these immune checkpoints, which are promising targets for antitumor immunotherapy. This evidence concerns the gene LAG3 and hepatocellular carcinoma.